Idenix Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Idenix Pharmaceuticals Ownership

Who owns Idenix Pharmaceuticals?

Idenix Pharmaceuticals is owned by Merck. It was acquired on August 5, 2014.

Idenix Pharmaceuticals Business Overview

Where is Idenix Pharmaceuticals headquartered?

Idenix Pharmaceuticals is headquartered in Cambridge, Massachusetts.

How many employees does Idenix Pharmaceuticals have?

Idenix Pharmaceuticals has 143 employees.

What sector is Idenix Pharmaceuticals in?

Idenix Pharmaceuticals is a life science company.

When was Idenix Pharmaceuticals founded?

Idenix Pharmaceuticals was founded in 1998.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.

Idenix Pharmaceuticals, Inc.

320 Bent Street,
Cambridge, Massachusetts 02141
United States,
(617) 995-9800
www.idenix.com

Idenix Pharmaceuticals, Inc., is a biopharmaceutical company engaged in the discovery and development of medicines for the treatment of human viral diseases, whose primary focus is on the development of next-generation oral antiviral therapeutics to treat hepatitis C virus (HCV) infection.


 Subscribe to unlock this and 205,946
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.